US Stock MarketDetailed Quotes

PCVX Vaxcyte

Watchlist
  • 69.500
  • +0.610+0.89%
Trading Mar 11 09:37 ET
8.95BMarket Cap-18.29P/E (TTM)

Vaxcyte Key Stats

Vaxcyte Q4 2024 Earnings Date

Currency:USDFeb 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-1.21
-1.02
+0.19
Beat Est.
+33.34%
+43.96%
+15.92%
Net Income
--
-137.08M
--
+24.18%
Strong Buy

Mar 11, 2025

Vaxcyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Feb 25, 20252024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Feb 25, 20252024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Vaxcyte Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 11, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data